Package nephro. February 23, 2015
|
|
|
- Veronica Hardy
- 10 years ago
- Views:
Transcription
1 Type Pack Title Biostatistics Utilities for Nephrology Version 1.1 Date Author Pack nephro February 23, 2015 Maintainer Set of functions to estimate the Glomerular Filtration Rate (GFR) using different biomarkers and other phenotypes of interest for nephrology. License GPL (>= 3) NeedsCompilation no Repository CRAN Date/Publication :25:54 R topics documented: nephro-pack CG CKDEpi.creat CKDEpi.creat.cys CKDEpi.cys MDRD MDRD Stevens.creat.cys Stevens.cys Stevens.cys Virga Index 13 1
2 2 nephro-pack nephro-pack Biostatistics Utilities for Nephrology Details This pack contains a set of tools for the estimation of renal function. Renal function is assessed by means of the Glomerular Filtration Rate (GFR) which can be estimated using different biomarkers. The most commonly used ones are serum or plasma and cystatin C. Included in this pack are the following GFR estimating functions: the Modification of Diet in Renal Disease (MDRD) study equation based on four (MDRD4) or six (MDRD6) parameters (see Levey 1999, 2006); the CKD-Epi equations for (CKDEpi.creat), cystatin C (CKDEpi.cys), and a combination of and cystatin C (CKDEpi.creat.cys) (see Inker 2012); the three equations proposed by Stevens 2008 based on cystatin C only (Stevens.cys1), - and -weighted cystatin C (Stevens.cys2), and a combination of cystatin C and (Stevens.creat.cys); the classic Cockroft and Gault 1976 equation for clearance estimation (CG); and the recent equation by Virga (2007) (Virga). A comparative description of several functions included in the pack can be found in Pattaro (2013). An extensive literature does exist that compares the methods described. Pack: nephro Type: Pack Version: 1.1 Date: License: GPLv3 <[email protected]> Acknowledgements: Max Plischke (contributed examples and bug reporting) Citing this pack: - Pattaro C, Riegler P, Stifter G, Modenese M, Minelli C, Pramstaller PP. Estimating the glomerular filtration rate in the general population using different equations: effects on classification and association. Nephron Clin Pract 2013; 123(1-2): Formulas: - Cockroft DW, Gault MH. Prediction of clearance from serum. Nephron 1976;
3 nephro-pack 3 16: Inker LA, et al. Estimating glomerular filtration rate from serum and cystatin C. N Engl J Med 2012; 367: Levey AS, et al. A more accurate method to estimate glomerular filtration rate from serum : a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130(6): Levey AS, et al. Using standardized serum values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006; 145: Stevens LA, et al. Estimating GFR using serum cystatin C alone and in combination with serum : a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008; 51: Virga G, et al. A new equation for estimating renal function using, body weight and serum. Nephron Clin Pract 2007; 105: c On IDMS calibration: - Levey AS, et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum values. Clin Chem 2007; 53: Matsushita K, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. J Am Med Assoc 2012; 307: Skali H, et al. Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation. Am Heart J 2011; 162: Examples # Comparison between different equations creat <- c(0.8, 0.9, 1.0, 1.1, 1.2, 1.3) cyst <- c(1.1, 0.95, 1.1, 1.0, 1.3, 1.2) <- c(1, 1, 1, 0, 0, 0) <- c(60, 65, 43, 82, 71, 55) ethn <- round(runif(6)) wt <- c(70, 80, 60, 55, 87, 71) egfr <- data.frame(creat, cyst) egfr$mdrd4 <- MDRD4(creat,,, ethn, IDMS ) egfr$ckdepi.creat <- CKDEpi.creat(creat,,, ethn) egfr$ckdepi.cys <- CKDEpi.cys(cyst,, ) egfr$ckdepi.creat.cys <- CKDEpi.creat.cys(creat, cyst,,, ethn) egfr$stevens.cys1 <- Stevens.cys1(cyst) egfr$stevens.cys2 <- Stevens.cys2(cyst,,, ethn) egfr$stevens.creat.cys <- Stevens.creat.cys(creat, cyst,,, ethn) egfr$cg <- CG(creat,,, wt) egfr$virga <- Virga(creat,,, wt) pairs(egfr[,3:11])
4 4 CG # For use with non-idms calibrated # several authors (see references) suggested # a 5% adjustment creat <- c(0.8, 0.9, 1.0, 1.1, 1.2, 1.3) <- c(1, 1, 1, 0, 0, 0) <- c(60, 65, 43, 82, 71, 55) ethn <- round(runif(6)) gfr <- CKDEpi.creat(0.95*creat,,, ethn) CG Cockroft and Gault equation Creatinine clearance is estimated with the Cockroft and Gault formula. CG(,,, wt) wt Numeric vector with serum or plasma values in mg/dl Numeric vector with in years Numeric vector with weight in kg Cockroft DW, Gault MH. Prediction of clearance from serum. Nephron 1976; 16: CKDEpi.creat, MDRD4, Virga
5 CKDEpi.creat 5 CKDEpi.creat CKD-EPI equation for serum GFR is estimated with the CKD-EPI Study equation based on IDMS serum or plasma. CKDEpi.creat(,,, ethnicity) ethnicity Numeric vector with serum or plasma values in mg/dl Numeric vector with in years Numeric vector with 0 for non-black and 1 for Black individuals Inker LA, et al. Estimating glomerular filtration rate from serum and cystatin C. N Engl J Med 2012; 367: CKDEpi.creat.cys, CKDEpi.cys
6 6 CKDEpi.creat.cys CKDEpi.creat.cys CKD-EPI equation for and cystatin C CKD-EPI equation to estimate GFR based on a combination of and cystatin C CKDEpi.creat.cys(, cystatin,,, ethnicity) cystatin ethnicity Numeric vector with serum or plasma values in mg/dl Numeric vector with serum or plasma cystatin C values in mg/dl Numeric vector with in years Numeric vector with 0 for non-black and 1 for Black individuals Inker LA, et al. Estimating glomerular filtration rate from serum and cystatin C. N Engl J Med 2012; 367: CKDEpi.creat, CKDEpi.cys
7 CKDEpi.cys 7 CKDEpi.cys CKD-EPI equation for cystatin C GFR is estimated with the CKD-EPI equation for cystatin C proposed by Inker et al., N Engl J Med 2012 CKDEpi.cys(cystatin,, ) cystatin Numeric vector with serum or plasma cystatin C values in mg/dl Numeric vector with in years The function returns a numeric vector with egfr values in ml/min/1.73 m 2. Inker LA, et al. Estimating glomerular filtration rate from serum and cystatin C. N Engl J Med 2012; 367: CKDEpi.creat, CKDEpi.creat.cys MDRD4 Four-parameter MDRD study equation GFR is estimated with the 4-parameter Modification of Diet in Renal Disease (MDRD) study equation. MDRD4(,,, ethnicity, method = "IDMS")
8 8 MDRD6 ethnicity method Numeric vector with serum or plasma values in mg/dl Numeric vector with in years Numeric vector with 0 for non-black and 1 for Black individuals Defaults is IDMS for IDMS-traceable ; write other if not IDMS Levey AS, et al. A more accurate method to estimate glomerular filtration rate from serum : a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130(6): Levey AS, et al. Using standardized serum values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006; 145: CKDEpi.creat, MDRD6, CG MDRD6 Six-parameter MDRD study equation GFR is estimated with the 6-parameter Modification of Diet in Renal Disease (MDRD) study equation. MDRD6(,,, albumin, BUN, ethnicity, method = IDMS )
9 Stevens.creat.cys 9 albumin BUN ethnicity method Numeric vector with serum or plasma values in mg/dl Numeric vector with in years Numeric vector with serum or plasma albumin in g/dl Numeric vector with blood urea nitrogen levels in mg/dl Numeric vector with 0 for non-black and 1 for Black individuals Defaults is IDMS for IDMS-traceable ; write other if not IDMS Levey AS, et al. A more accurate method to estimate glomerular filtration rate from serum : a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130(6): Levey AS, et al. Using standardized serum values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006; 145: MDRD4 Stevens.creat.cys Stevens formula for a combination of serum and cystatin C GFR estimation using the 3rd formula proposed by Stevens et al. (Am J Kidney Dis 2008), which combines and cystatin C Stevens.creat.cys(, cystatin,,, ethnicity)
10 10 Stevens.cys1 cystatin ethnicity Numeric vector with serum or plasma values in mg/dl Numeric vector with serum or plasma cystatin C values in mg/dl Numeric vector with in years Numeric vector with 0 for non-black and 1 for Black individuals The function returns a numeric vector with egfr values in ml/min/1.73 m 2. Stevens LA, et al. Estimating GFR using serum cystatin C alone and in combination with serum : a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008; 51: CKDEpi.creat.cys Stevens.cys1 GFR estimation using serum cystatin C GFR is estimated with the 1st formula proposed by Stevens et al. (Am J Kidney Dis 2008), i.e.: as a simple transformation of cystatin C, without using any other information Stevens.cys1(cystatin) cystatin Numeric vector with serum or plasma cystatin C values in mg/dl
11 Stevens.cys2 11 Stevens LA, et al. Estimating GFR using serum cystatin C alone and in combination with serum : a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008; 51: Stevens.cys2, Stevens.creat.cys, CKDEpi.cys Stevens.cys2 Stevens formula for serum cystatin C,, and GFR is estimated with the 2nd formula proposed by Stevens et al. (Am J Kidney Dis 2008), where cystatin C is weighted by and Stevens.cys2(cystatin,,, ethnicity) cystatin ethnicity Numeric vector with serum or plasma cystatin C values in mg/dl Numeric vector with in years Numeric vector with 0 for non-black and 1 for Black individuals Stevens LA, et al. Estimating GFR using serum cystatin C alone and in combination with serum : a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008; 51: Stevens.cys1, Stevens.creat.cys, CKDEpi.cys
12 12 Virga Virga Virga s formula Virga s formula is based on serum,,, and body weight. Virga(,,, wt) wt Numeric vector with serum or plasma values in mg/dl Numeric 0/1 vector: 0 for females, 1 for males Numeric vector with in years Numeric vector with weight in kg A numeric vector with egfr values in ml/min/1.73 m^2 Virga G, et al. A new equation for estimating renal function using, body weight and serum. Nephron Clin Pract 2007; 105: c CG, MDRD4
13 Index Topic CKD-EPI CKDEpi.creat, 5 CKDEpi.creat.cys, 6 CKDEpi.cys, 7 Topic GFR, renal function, kidney, MDRD, CKD-EPI,, cystatin nephro-pack, 2 Topic GFR CKDEpi.cys, 7 Stevens.creat.cys, 9 Stevens.cys1, 10 Stevens.cys2, 11 Topic MDRD CG, 4 MDRD4, 7 MDRD6, 8 Topic Virga Virga, 12 Topic albumin MDRD6, 8 Topic blood urea nitrogen MDRD6, 8 Topic clearance CG, 4 Virga, 12 Topic CG, 4 CKDEpi.creat, 5 CKDEpi.creat.cys, 6 CKDEpi.cys, 7 MDRD4, 7 MDRD6, 8 Stevens.creat.cys, 9 Virga, 12 Topic cystatin CKDEpi.creat.cys, 6 CKDEpi.cys, 7 Stevens.creat.cys, 9 Stevens.cys1, 10 Stevens.cys2, 11 Topic nephro-pack, 2 CG, 2, 4, 8, 12 CKDEpi.creat, 2, 4, 5, 6 8 CKDEpi.creat.cys, 2, 5, 6, 7, 10 CKDEpi.cys, 2, 5, 6, 7, 11 MDRD4, 2, 4, 7, 9, 12 MDRD6, 2, 8, 8 nephro (nephro-pack), 2 nephro-pack, 2 Stevens.creat.cys, 2, 9, 11 Stevens.cys1, 2, 10, 11 Stevens.cys2, 2, 11, 11 Virga, 2, 4, 12 13
Estimated GFR Based on Creatinine and Cystatin C
Estimated GFR Based on Creatinine and Cystatin C Lesley A Stevens, MD, MS Tufts Medical Center, Tufts University School of Medicine Boston MA Chronic Kidney Disease-Epidemiology Collaboration UO1 DK 053869,
Nierfunctiemeting en follow-up van chronisch nierlijden
Nierfunctiemeting en follow-up van chronisch nierlijden 12 Jan 2016 Patrick Peeters, M.D. Dept Nephrology Ghent University Hospital Plan of presentation 1/ Renal function determination: Measured GFR Estimated
Chapter 6: Limitations of Various Formulae and Other Ways of Assessing GFR in the Elderly: Is There a Role for Cystatin C?
Chapter 6: Limitations of Various Formulae and Other Ways of Assessing GFR in the Elderly: Is There a Role for Cystatin C? Devraj Munikrishnappa Department of Internal Medicine, The Nephrology Division,
Calculating the stage of Renal Disease
Calculating the stage of Renal Disease When the Refresh Template/Check Labs button is depressed, the box next to MDRD, will be automatically checked. In order to use this in the calculation of the stage
KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA
KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA O.E. Stakhvoskyi, E.O. Stakhovsky, Y.V. Vitruk, O.A. Voylenko, P.S. Vukalovich, V.A. Kotov, O.M. Gavriluk National Canсer Institute,
Albuminuria versus GFR as markers of diabetic CKD progression
Albuminuria versus GFR as markers of diabetic CKD progression KDIGO Controversies Conference: Diabetic Kidney Disease New Delhi, March 2012 Richard J MacIsaac PhD FRACP Director of Endocrinology & Diabetes,
Renal Disease in Type 2 Diabetes Mellitus
Renal Disease in Type 2 Diabetes Mellitus 6th Collaborative DiGP/HSE/UCC Conference 25 th September 2013 Dr. Eoin O Sullivan Consultant Endocrinologist Bon Secours Hospital Cork Case 69 year old woman
Creatinine (serum, plasma)
Creatinine (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Creatinine 1.2 Alternative names None 1.3 Description of analyte Creatinine is a heterocyclic nitrogenous compound (IUPAC
Definition, Prevalence, Pathophysiology and Complications of CKD. JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013
Definition, Prevalence, Pathophysiology and Complications of CKD JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013 KI supplements January 2013 Objectives of the course on CKD:
Diabetes and the Kidneys
Diabetes and the Kidneys Aim(s) and objective(s) This guideline focuses on the detection, prevention, and management of kidney disease in people with diabetes. The management of end-stage renal disease
The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C:
The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C: The good correlation allows close estimation of GFR Cystatin C GFR GFR in serum estimated* measured* n
FREQUENTLY ASKED QUESTIONS ABOUT GFR ESTIMATES
FREQUENTLY ASKED QUESTIONS ABOUT GFR ESTIMATES TABLE OF CONTENTS MEASUREMENT OF KIDNEY FUNCTION 4 1) What is GFR? 4 2) How is GFR measured? 4 3) What does GFR indicate? 4 4) Why measure GFR as an index
Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한
Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한 Introduction CKD의 정의와 egfr의 측정 CKD의 risk factor와 mechanism 한국의 CKD prevalence 와 prognosis CKD의 치료와
Age- and gender-specific reference values of estimated GFR in Caucasians: The Nijmegen Biomedical Study
original article http://www.kidney-international.org & 2007 International Society of Nephrology see commentary on page 534 Age- and gender-specific reference values of estimated GFR in Caucasians: The
How To Diagnose And Treat Hyperphosphatemia
Electrolyte & Blood Pressure 5:335, 2007 Case report ) Pseudohyperphosphatemia in a Patient with Multiple Myeloma Yonggu Lee, M.D., Taiyon Koo, M.D., JooHark Yi, M.D., JungHye Choi, M.D. SangWoong Han,
Chronic Kidney Disease and the Electronic Health Record. Duaine Murphree, MD Sarah M. Thelen, MD
Chronic Kidney Disease and the Electronic Health Record Duaine Murphree, MD Sarah M. Thelen, MD Definition of Chronic Kidney Disease (CKD) Defined by the National Kidney Foundation Either a decline in
Renal Function Tests. Carmella L. D Addezio, DO, MS, FACOI, LTC, USAF, MC
Renal Function Tests Carmella L. D Addezio, DO, MS, FACOI, LTC, USAF, MC Goals and objectives At the end of this discussion you will be able to state: What test you should use to screen a patient for renal
GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY*
71 GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY* Ryuichi KIKKAWA** Asian Med. J. 44(2): 71 75, 2001 Abstract: Diabetic nephropathy is the most devastating complication of diabetes and is now the
Chapter 23. Composition and Properties of Urine
Chapter 23 Composition and Properties of Urine Composition and Properties of Urine urinalysis the examination of the physical and chemical properties of urine appearance - clear, almost colorless to deep
CHRONIC KIDNEY DISEASE MANAGEMENT GUIDE
CHRONIC KIDNEY DISEASE MANAGEMENT GUIDE Outline I. Introduction II. Identifying Members with Kidney Disease III. Clinical Guidelines for Kidney Disease A. Chronic Kidney Disease B. End Stage Renal Disease
Guideline for Microalbuminuria Screening
East Lancashire Diabetes Network Guideline for Microalbuminuria Screening Produced by: Task and Finish Group, Clinical Standards Group Produced: August 2006 Approved by: East Lancashire Diabetes Network
Chronic Kidney Disease and Diabetes
Anyone with diabetes can get kidney disease. Diabetes and high blood pressure are the most common causes of kidney disease, and people often have both. Chronic (long term) kidney disease (CKD) caused by
Prediction of Kidney Disease Progression in Patients with Diabetes
Prediction of Kidney Disease Progression in Patients with Diabetes John Arthur, MD, PhD Medical University of South Carolina SEKDC Meeting September 8, 2012 Objectives Understand the importance of predicting
How To Know If Low Protein Diet Is Beneficial For Kidney Health
Protein Intake and Diabetic Kidney Disease Robert C. Stanton Joslin Diabetes Center 1/Serum Creatinine Plot Low Protein Protects in Renal Ablation Model 24% Protein Diet 6% Protein Diet Right Nephrectomy
Renal function estimation: the implications for clinical practice. Iefke Drion
Renal function estimation: the implications for clinical practice Iefke Drion I. Drion Renal function estimation: the implications for clinical practice Cover design: J. Drion Cover photo: Tãtaru Sebastian
DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE DRUGS IN DIABETIC PATIENTS WITH CKD
WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Elhami et al. SJIF Impact Factor 5.210 Volume 4, Issue 11, 1159-1166 Research Article ISSN 2278 4357 DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE
AMOEBA (ISSN: 0926-3543)
AMOEBA (ISSN: 0926-3543) Available online at www.amoeba-journal.com Vol.40, No.05 Page: 144-150 (September 2015) Nederlandse jeugdbond voor natuurstudie, postbus 9955, s graveland, netherlands, 1243 zs
Effect of Elevated Creatinine Level in Blood Serum of Chronic Renal Failure Patients
Biological Forum An International Journal 6(1): 48-52(2014) ISSN No. (Print): 0975-1130 ISSN No. (Online): 2249-3239 Effect of Elevated Creatinine Level in Blood Serum of Chronic Renal Failure Patients
FREQUENTLY ASKED QUESTIONS ABOUT GFR ESTIMATES
FREQUENTLY ASKED QUESTIONS ABOUT GFR ESTIMATES TABLE OF CONTENTS MEASUREMENT OF KIDNEY FUNCTION 4 1) What is GFR? 4 2) How is GFR measured? 4 3) What does GFR indicate? 4 4) Why measure GFR as an index
10/27/2010. CKD in the United States. Management of The Patient With Chronic Kidney Disease. CKD Patients Are More Likely to Die Than Progress to ESRD
CKD in the United States Management of The Patient With Chronic Kidney Disease Paul J. Scheel, Jr., M.D., FASN Director,Division of Nephrology An estimated 26 million adults have CKD Many are unaware of
What is creatinine? The kidneys maintain the blood creatinine in a normal range. Creatinine has been found to be a fairly reliable indicator of kidney
What is creatinine? Creatinine is a chemical waste molecule that is generated from muscle metabolism. Creatinine is produced from creatine, a molecule of major importance for energy production in muscles.
Diabetic Nephropathy
Diabetic Nephropathy Kidney disease is common in people affected by diabetes mellitus Definition Urinary albumin excretion of more than 300mg in a 24 hour collection or macroalbuminuria Abnormal renal
Correspondence to: Rima B Shah ([email protected]) DOI: 10.5455/ijmsph.2013.2.167-172 Received Date: 29.11.2012 Accepted Date: 03.12.
RESEARCH ARTICLE STUDY OF UTILIZATION PATTERN OF ANTI-HYPERTENSIVE DRUGS IN HYPERTENSIVE DIABETIC PATIENTS WITH OR WITHOUT REDUCED RENAL FUNCTION AT TERTIARY CARE TEACHING HOSPITAL Jay Shah 1, Tejas Khakhkhar
Urine Protein/Creatinine Ratio as a Mortality Risk Predictor in Non-Diabetics with Normal Renal Function
JOURNAL OF INSURANCE MEDICINE Copyright E 2012 Journal of Insurance Medicine J Insur Med 2012;43:76 83 MORTALITY Urine Protein/Creatinine Ratio as a Mortality Risk Predictor in Non-Diabetics with Normal
survival, morality, & causes of death Chapter Nine introduction 152 mortality in high- & low-risk patients 154 predictors of mortality 156
introduction 152 < mortality in high- & low-risk patients 154 < predictors of mortality 156 < impact of anemia & dialysis therapy on mortality 158 < mortality in esrd patients with rare s 16 < expected
Epidemiology of Diabetic Kidney Disease
Epidemiology of Diabetic Kidney Disease Anne T. Reutens, MBBS, PhD, FRACP a,b, * KEYWORDS Diabetes Prevalence Incidence Microalbuminuria Macroalbuminuria End-stage renal disease KEY POINTS Diabetic kidney
Primary prevention of chronic kidney disease: managing diabetes mellitus to reduce the risk of progression to CKD
Primary prevention of chronic kidney disease: managing diabetes mellitus to reduce the risk of progression to CKD Date written: July 2012 Author: Kate Wiggins, Graeme Turner, David Johnson GUIDELINES We
The definition, classification and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
http://www.kidney-international.org & 2010 International Society of Nephrology public forum The definition, classification and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
How To Test For Creatinine
Creatinine is measured amperometrically. Creatinine is hydrolyzed to creatine in a reaction catalyzed by the enzyme creatinine amidohydrolase. Creatine is then hydrolyzed to sarcosine in a reaction catalyzed
Assessment of kidney function in type 2 diabetes
NEPHROLOGY 2010; 15, S146 S161 doi:10.1111/j.1440-1797.2010.01239.x Assessment of kidney function in type 2 diabetes Date written: April 2009 Final submission: April 2009 Author: Chadban S, Howell M, Twigg
Diagnostic Assessments Relating to Renal Function: Why we do them? What do they mean? Mohamud Karim MD, FRCPC. Feb 27, 2015
Diagnostic Assessments Relating to Renal Function: Why we do them? What do they mean? Mohamud Karim MD, FRCPC Feb 27, 2015 Acknowledgements: Previous presentor Why are Patients Referred? Renal Syndromes:
Hydration Protocol for Cisplatin Chemotherapy
Betsi Cadwaladr University Health Version: 1.3 CSPM2 Hydration Protocol for Cisplatin Chemotherapy Date to be reviewed: July 2018 No of pages: 9 Author(s): Tracy Parry-Jones Author(s) title: Lead Cancer
KDIGO THE GEORGE INSTITUTE FOR GLOBAL HEALTH. Antiocoagulation in diabetes and CKD Vlado Perkovic
THE GEORGE INSTITUTE FOR GLOBAL HEALTH Antiocoagulation in diabetes and CKD Vlado Perkovic Executive Director, George Institute Australia Professor of Medicine, University of Sydney Affiliated with the
Risk Benefit of Apixaban and Other New Oral Anticoagulants Compared with Standard of Care for the Prevention of Stroke
Risk Benefit of Apixaban and Other New Oral Anticoagulants Compared with Standard of Care for the Prevention of Stroke Alexander Niessner Medical University of Vienna Content Unmet needs in atrial fibrillation
Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results
Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and
GFR (Glomerular Filtration Rate) A Key to Understanding How Well Your Kidneys Are Working
GFR (Glomerular Filtration Rate) A Key to Understanding How Well Your Kidneys Are Working www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National
1/12/2016. What s in a name? What s in a name? NO.Anti-Coagulation. DOACs in clinical practice. Practical aspects of using
What s in a name? Practical aspects of using DOACs (Direct Oral Anticoagulants) James L. Sebastian, MD, MACP Professor of Medicine (GIM) Medical College of Wisconsin February 5, 2016 DOAC NOAC NOAC ODI
High Blood Pressure and Kidney Disease
High Blood Pressure and Kidney Disease National Kidney and Urologic Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH The kidneys play a key
Kidney Disease: Key Facts and Figures. September 2010
Kidney Disease: Key Facts and Figures September 2010 ii Kidney Disease Key Facts and Figures Contents Introduction... 1 1 Kidney disease common definitions... 2 1.1 Chronic kidney disease... 2 1.2 Acute
Risk Factors of chronic complex co-morbidities. Aldo Pietro Maggioni, MD ANMCO Research Center Firenze, Italy
Risk Factors of chronic complex co-morbidities Aldo Pietro Maggioni, MD ANMCO Research Center Firenze, Italy Statement 1 In real world practice (and in clinical trials), complex co-morbidities are the
ΠΟΙΟ ΑΝΤΙΠΗΚΤΙΚΟ ΓΙΑ ΤΟΝ ΑΣΘΕΝΗ ΜΟΥ? ΚΛΙΝΙΚΑ ΠΑΡΑΔΕΙΓΜΑΤΑ. Σωκράτης Παστρωμάς Καρδιολόγος Νοσοκομείο Ερρίκος Ντυνάν
ΠΟΙΟ ΑΝΤΙΠΗΚΤΙΚΟ ΓΙΑ ΤΟΝ ΑΣΘΕΝΗ ΜΟΥ? ΚΛΙΝΙΚΑ ΠΑΡΑΔΕΙΓΜΑΤΑ Σωκράτης Παστρωμάς Καρδιολόγος Νοσοκομείο Ερρίκος Ντυνάν The AF epidemic Mayo Clinic data (assuming a continued increase in the AF incidence) Mayo
NOAC Prescribing in Patients with Non-Valvular Atrial Fibrillation: Frequently Asked Questions
AC Prescribing in Patients with Non-Valvular Atrial Fibrillation: Frequently Asked Questions FAQ document jointly prepared by NHSGGC Haematology Service & Medicines Infmation On behalf of the Heart MCN
NUTRITION IN LIVER DISEASES
NUTRITION IN LIVER DISEASES 1. HEPATITIS: Definition: - Viral inflammation of liver cells. Types: a. HAV& HEV, transmitted by fecal-oral route. b. HBV & HCV, transmitted by blood and body fluids. c. HDV
Improvement of Diagnosis Coding by Analysing EHR and Using Rule Engine: Application to the Chronic Kidney Disease
120 Digital Healthcare Empowering Europeans R. Cornet et al. (Eds.) 2015 European Federation for Medical Informatics (EFMI). This article is published online with Open Access by IOS Press and distributed
Models of Chronic Kidney Disease Care and Initiation of Dialysis. Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK
Models of Chronic Kidney Disease Care and Initiation of Dialysis Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK Early Crash Landings Talk Outline Pathways & Definitions Guideline recommendations
Renal Topics 1) renal function 2) renal system 3) urine formation 4) urine & urination 5) renal diseases
Renal Topics 1) renal function 2) renal system 3) urine formation 4) urine & urination 5) renal diseases 1/9/2015 Renal Biology - Sandra Hsu 1 Renal Functions 1) excrete metabolic wastes (blood cleaning)
Prognostic impact of uric acid in patients with stable coronary artery disease
Prognostic impact of uric acid in patients with stable coronary artery disease Gjin Ndrepepa, Siegmund Braun, Martin Hadamitzky, Massimiliano Fusaro, Hans-Ullrich Haase, Kathrin A. Birkmeier, Albert Schomig,
LECTURE 1 RENAL FUNCTION
LECTURE 1 RENAL FUNCTION Components of the Urinary System 2 Kidneys 2 Ureters Bladder Urethra Refer to Renal System Vocabulary in your notes Figure 2-1,page10 Kidney Composition Cortex Outer region Contains
Dialysis Patients' Bill of Rights and Responsibilities
Dialysis Patients' Bill of Rights and Responsibilities PATIENTS Rights Quality Care Information Individual Treatment Privacy and Confidentiality Services Without Discrimination Treatment Options Kidney
Chronic Kidney Disease (CKD) Algorithm. Chronic Kidney Disease (CKD) Algorithm Page 1
Chronic Kidney Disease (CKD) Algorithm Chronic Kidney Disease (CKD) Algorithm Page 1 Chronic Kidney Disease (CKD) Algorithm (See NICE Clinical Guideline CG73 1 and Quality Standards 2 ) Who should have
Save the Vein: What Nurses Need to Know. Objectives. Importance of Vein Preservation. Why Focus on Vein Preservation? Chronic Kidney Disease
Description: This program focuses on the importance of vein preservation in chronic kidney disease (CKD) patients. At the heart of this project is a silicone wristband that reads SAVE VEINS NO IV/LAB DRAWS.
JNC-8 Blood Pressure and ACC/AHA Cholesterol Guideline Updates. January 30, 2014
JNC-8 Blood Pressure and ACC/AHA Cholesterol Guideline Updates January 30, 2014 GOALS Review key recommendations from recently published guidelines on blood pressure and cholesterol management Discuss
Acute Pancreatitis. Questionnaire. if yes: amount (cigarettes/day): since when (year): Drug consumption: yes / no if yes: type of drug:. amount:.
The physical examination has to be done AT ADMISSION! The blood for laboratory parameters has to be drawn AT ADMISSION! This form has to be filled AT ADMISSION! Questionnaire Country: 1. Patient personal
